Copyright: ©Author(s) 2026.
World J Hepatol. Mar 27, 2026; 18(3): 117134
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.117134
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.117134
Figure 2 Integrated analysis of global hepatocellular carcinoma gene microarray and high-throughput sequencing data.
A: Cullin-2 mRNA is significantly overexpressed in 5204 hepatocellular carcinoma tissues compared to 4079 non-cancerous tissues; B: Sensitivity analysis results indicate stability of the standardized mean difference, as assessed by publication bias test; C: Begg’s test; D: Egger’s test; E: Pooled receiver operating characteristic curve analysis. SROC: Summary receiver operating characteristic; SMD: Standardized mean difference.
- Citation: Tang P, Nong QH, Xiong KH, Tang HH, Huang BB, Huang GL, Li Q, He SP, Chen G, Feng ZB, Li JD. Overexpression and clinicopathological significance of cullin-2 in hepatocellular carcinoma progression. World J Hepatol 2026; 18(3): 117134
- URL: https://www.wjgnet.com/1948-5182/full/v18/i3/117134.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i3.117134